No Data
No Data
US MOVERS&SHAKERS Sep 09-Sep 13, 2024
AstraZeneca, Daiichi Sankyo Reports Safety Profile of Breast Cancer Drug in Phase 3b/4 Study
AstraZeneca Chair Shows Confidence With Share Purchase
AstraZeneca, Roche Cut at Deutsche After Trial Readouts for Key Drugs
Express News | AstraZeneca And Daiichi Sankyo To Present Findings Of ENHERTU Showing Clinical Activity In Patients With HER2 Positive Metastatic Breast Cancer And Brain Metastases
ENHERTU (Fam-trastuzumab Deruxtecan-nxki) Showed Substantial Clinical Activity in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastases
102685190 : xuu x 7j vxx u6 xjg uxi, cm, xc j, xz m rx xjdd b8kbnxckvxz6ckbm.ust
74423696 : Good morning dear ; thank you so much for all your help and support .
Neomonoman : look at the price and trend, all these recommendations are so wrong
webguybob : buy the Adobe dip?
身骑白马 : good